D.E. Shaw & Co
OM icon

D.E. Shaw & Co’s Outset Medical OM Stock Holding History

D.E. Shaw & Co’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-28,576
Closed -$290K – 4736
2024
Q3 		$290K Sell
28,576
-56,567
-66% -$1.68M ﹤0.01% 3991
2024
Q2 		$4.92M Sell
85,143
-27,218
-24% -$1.33M ﹤0.01% 1866
2024
Q1 		$3.74M Buy
112,361
+56,911
+103% +$2.88M ﹤0.01% 2120
2023
Q4 		$4.5M Buy
55,450
+51,434
+1,281% +$4.19M ﹤0.01% 1988
2023
Q3 		$655K Sell
4,016
-21,142
-84% -$4.99M ﹤0.01% 3312
2023
Q2 		$8.25M Sell
25,158
-8,566
-25% -$2.61M 0.01% 1495
2023
Q1 		$9.31M Buy
33,724
+13,024
+63% +$4.78M 0.01% 1431
2022
Q4 		$8.02M Buy
+20,700
New +$5.84M 0.01% 1648

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co's OM Position: Q4 2024 in Review

D.E. Shaw & Co sold out of Outset Medical (OM) in Q4 2024, closing a stake of 28,576 shares — an estimated $290K sold.

D.E. Shaw & Co first reported a position in OM in Q4 2022 and held it in 8 quarters. The position peaked at $9.31M in Q1 2023. 73 funds tracked by Wall St. Rank hold OM as of Q4 2024.

  • D.E. Shaw & Co reported no remaining Outset Medical position as of Q4 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 28,576 Outset Medical shares in Q4 2024, an estimated $290K.
  • D.E. Shaw & Co first reported a position in Outset Medical in Q4 2022 and held it in 8 quarters.
  • D.E. Shaw & Co's Outset Medical position peaked at $9.31M in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Outset Medical as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.